Axcella Health (NASDAQ:AXLA) Announces Quarterly Earnings Results, Misses Estimates By $0.31 EPS

Share on StockTwits

Axcella Health (NASDAQ:AXLA) released its quarterly earnings data on Monday. The company reported ($0.95) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.64) by ($0.31), Bloomberg Earnings reports.

Shares of NASDAQ:AXLA opened at $7.00 on Tuesday. The firm has a fifty day moving average price of $8.24. Axcella Health has a one year low of $6.10 and a one year high of $15.99.

AXLA has been the subject of several analyst reports. Leerink Swann initiated coverage on shares of Axcella Health in a report on Monday, June 3rd. They issued an “outperform” rating for the company. JPMorgan Chase & Co. initiated coverage on shares of Axcella Health in a report on Monday, June 3rd. They issued an “overweight” rating and a $20.00 price objective for the company. Zacks Investment Research downgraded shares of Axcella Health from a “hold” rating to a “sell” rating in a report on Wednesday, August 7th. Svb Leerink initiated coverage on shares of Axcella Health in a report on Monday, June 3rd. They issued an “outperform” rating and a $21.00 price objective for the company. Finally, Goldman Sachs Group initiated coverage on shares of Axcella Health in a report on Sunday, June 2nd. They issued a “buy” rating and a $25.00 price objective for the company. One investment analyst has rated the stock with a sell rating and four have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $22.00.

In related news, Director David R. Epstein acquired 14,500 shares of the stock in a transaction dated Wednesday, June 26th. The shares were purchased at an average price of $9.57 per share, for a total transaction of $138,765.00. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director David R. Epstein acquired 6,941 shares of the stock in a transaction dated Friday, August 2nd. The shares were bought at an average price of $7.00 per share, for a total transaction of $48,587.00. The disclosure for this purchase can be found here. Over the last three months, insiders acquired 38,293 shares of company stock valued at $337,682.

About Axcella Health

There is no company description available for Axcella Health Inc

See Also: After-Hours Trading

Receive News & Ratings for Axcella Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcella Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Sutro Biopharma Inc  Expected to Post Quarterly Sales of $8.88 Million
Sutro Biopharma Inc Expected to Post Quarterly Sales of $8.88 Million
$0.15 EPS Expected for Earthstone Energy Inc  This Quarter
$0.15 EPS Expected for Earthstone Energy Inc This Quarter
Zacks: Analysts Expect Earthstone Energy Inc  Will Post Quarterly Sales of $41.66 Million
Zacks: Analysts Expect Earthstone Energy Inc Will Post Quarterly Sales of $41.66 Million
Brokerages Expect Sensata Technologies Holding PLC  to Announce $0.90 EPS
Brokerages Expect Sensata Technologies Holding PLC to Announce $0.90 EPS
$855.78 Million in Sales Expected for Sensata Technologies Holding PLC  This Quarter
$855.78 Million in Sales Expected for Sensata Technologies Holding PLC This Quarter
Zacks: Brokerages Anticipate Las Vegas Sands Corp.  to Announce $0.78 Earnings Per Share
Zacks: Brokerages Anticipate Las Vegas Sands Corp. to Announce $0.78 Earnings Per Share


© 2006-2019 Ticker Report